Svetlana Donina - Concepedia

Author

Svetlana Donina

Institute of Experimental Medicine ORCID

Also Known As

L G Rudenko, S A Donina, S. A. Donina, Svetlana A. Donina, Svetlana A Donina, Svetlana A. Donina, Svetlana Donina

Publications

620

Citations

H-Index

Concepts

All Affiliations

Institute of Experimental Medicine Research Institute of Influenza Centers for Disease Control and Prevention Czech Academy of Sciences, Institute of Experimental Medicine Seattle University

About

Svetlana Donina is an author at Institute of Experimental Medicine specializing in vaccination, medicine, and influenza vaccines.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	377
2	Immunology	10	10	271
3	Public Health	2	2	106
4	Allergy	2	2	57
5	Epidemiology	2	2	55

Svetlana Donina

Publications

568

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents Larisa Rudenko, Nancy H. Arden, Elena Grigorieva, Vaccine VaccinationVaccine SafetyVaccinologyRussian LiveVaccine Efficacy	2000	77
Assessment of Human Immune Responses to H7 Avian Influenza Virus of Pandemic Potential: Results from a Placebo–Controlled, Randomized Double–Blind Phase I Study of Live Attenuated H7N3 Influenza Vaccine Larisa Rudenko, Irina Kiseleva, Anatoly Naykhin, PLoS ONE	2014	57
Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I–II clinical trials) Larisa Rudenko, Yulia Desheva, Sergey A. Korovkin, Influenza and Other Respiratory Viruses	2008	56
Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin Irina Isakova–Sivak, Daniil Korenkov, Tatiana Smolonogina, Virology VaccinationCross-protectionImmunologyChimeric HemagglutininVirology	2018	37
Memory T-Cell Immune Response in Healthy Young Adults Vaccinated with Live Attenuated Influenza A (H5N2) Vaccine Tatiana Chirkova, Anatoly Naykhin, Galina Petukhova, Clinical and Vaccine Immunology Immune ActivationImmunologyImmunodominanceHealthy Young AdultsCd4 T Cell Responses	2011	33
H7N3 live attenuated influenza vaccine has a potential to protect against new H7N9 avian influenza virus Larisa Rudenko, Irina Isakova–Sivak, Svetlana Donina Vaccine VaccinationVaccine DevelopmentVaccine TargetImmunologyVirology	2013	32
Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine Larisa Rudenko, Anatoly Naykhin, Svetlana Donina, Human Vaccines & Immunotherapeutics	2015	30
Cross-Reactivity of SARS-CoV-2 Nucleocapsid-Binding Antibodies and Its Implication for COVID-19 Serology Tests Alexandra Rak, Svetlana Donina, Yana Zabrodskaya, Viruses Viral DiagnosticsViral PathogenesisImmunologyDifferent VocsViral Structural Protein	2022	30
Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers: Results from a placebo-controlled, randomized double-blind phase I study Larisa Rudenko, Irina Kiseleva, Marina Stukova, Vaccine VaccinationCross-protectionPreventive MedicineClinical TestingVaccine Testing	2015	29
Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method Galina Petukhova, Tatiana Chirkova, Svetlana Donina, Vaccine VaccinationMucosal VaccinationVaccine DevelopmentLocal AntibodyImmunology	2009	26

Page 1